Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example.

Public health genomics - 1 Jan 2010

Li-Wan-Po A, Farndon P, Cooley C, Lithgow J

Abstract excerpt

Advances in genomics promise to deliver personalized medicine both for prevention and treatment of disease. Considerable effort is being directed towards translating observed associations between various genetic variants, such as single nucleotide polymorphisms (SNPs), and disease or drug response into clinically useful genetic tests. Unfortunately, because reported associations are usually weak or moderate,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Genetic Predisposition to Disease
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 19439915
DOI: 10.1159/000218710

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example.PMID 19439915Read ↗

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.Semantic proximity Read ↗

A genetic-based approach to personalized prostate cancer screening and treatment.Semantic proximity Read ↗

A comparison of genetic risk score with family history for estimating prostate cancer risk.Semantic proximity Read ↗

Clinical validity and utility of genetic risk scores in prostate cancer.Semantic proximity Read ↗

Personalized prostate cancer screening: improving PSA tests with genomic information.Semantic proximity Read ↗

Utility of genome-wide association study findings: prostate cancer as a translational research paradigm.Semantic proximity Read ↗

Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.Semantic proximity Read ↗

Genetic testing for the clinician in prostate cancer.Semantic proximity Read ↗

Guidelines for genetic testing in prostate cancer: a scoping review.Semantic proximity Read ↗

Multigene panels in prostate cancer risk assessment: a systematic review.Semantic proximity Read ↗

Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate CancerSemantic proximity Read ↗

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.